Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$1.23B |
| 2 |
Uber
UBER
|
$514M |
| 3 |
Walt Disney
DIS
|
$475M |
| 4 |
Analog Devices
ADI
|
$469M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$391M |
Top Sells
| 1 |
Amazon
AMZN
|
$1.58B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$1.14B |
| 3 |
Bristol-Myers Squibb
BMY
|
$434M |
| 4 |
JPMorgan Chase
JPM
|
$415M |
| 5 |
Morgan Stanley
MS
|
$397M |
Sector Composition
| 1 | Technology | 15.82% |
| 2 | Healthcare | 13.61% |
| 3 | Industrials | 8.61% |
| 4 | Financials | 8.49% |
| 5 | Consumer Discretionary | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Clorox
CLX
$14.6B
| $62.7M | 0.02% |
310,728
-54,574
| -15% | -$11M |
|
302
QuantumScape
QS
$4.31B
| $62.7M | 0.02% |
742,329
+83,818
| +13% | +$7.08M |
|
303
Aecom
ACM
$16.4B
| $62.4M | 0.02% |
1,252,794
+837,506
| +202% | +$41.7M |
|
304
NVR
NVR
$22.5B
| $62.3M | 0.02% |
15,267
+11,969
| +363% | +$48.8M |
|
305
Ryman Hospitality Properties
RHP
$6.12B
| $62M | 0.02% |
915,492
+386,690
| +73% | +$26.2M |
|
|
DCT
306
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $62M | 0.02% |
1,432,595
+247,929
| +21% | +$10.7M |
|
307
Markel Group
MKL
$24.4B
| $61.9M | 0.02% |
59,941
+37,190
| +163% | +$38.4M |
|
308
Iovance Biotherapeutics
IOVA
$796M
| $61.5M | 0.02% |
1,325,892
+34,494
| +3% | +$1.6M |
|
309
Intellia Therapeutics
NTLA
$1.22B
| $61.4M | 0.02% |
1,129,399
+293,613
| +35% | +$16M |
|
310
Sunrun
RUN
$3.66B
| $61.4M | 0.02% |
884,738
-16,342
| -2% | -$1.13M |
|
311
Woodward
WWD
$14.6B
| $60.9M | 0.02% |
501,402
+136,535
| +37% | +$16.6M |
|
312
Qorvo
QRVO
$8.22B
| $60.8M | 0.02% |
365,901
-1,107,739
| -75% | -$184M |
|
313
Tradeweb Markets
TW
$26B
| $60.8M | 0.02% |
973,319
+721,487
| +286% | +$45.1M |
|
|
ONCR
314
DELISTED
Oncorus, Inc.
ONCR
| $60.8M | 0.02% |
+1,879,337
| New | +$60.8M |
|
315
Globe Life
GL
$11.2B
| $60.5M | 0.02% |
637,233
-974,517
| -60% | -$92.5M |
|
|
TRIL
316
DELISTED
Trillium Therapeutics Inc.
TRIL
| $60.4M | 0.02% |
4,103,122
+359,710
| +10% | +$5.29M |
|
317
Elevance Health
ELV
$72.8B
| $60.3M | 0.02% |
187,769
+138,207
| +279% | +$44.4M |
|
|
ATH
318
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $60M | 0.02% |
1,390,219
+1,090,847
| +364% | +$47.1M |
|
319
Gentex
GNTX
$6.06B
| $59.8M | 0.02% |
1,763,006
+1,578,528
| +856% | +$53.6M |
|
320
Expedia Group
EXPE
$26B
| $59.7M | 0.02% |
451,054
+434,143
| +2,567% | +$57.5M |
|
321
ConocoPhillips
COP
$123B
| $59.6M | 0.02% |
1,490,250
+1,252,455
| +527% | +$50.1M |
|
322
NNN REIT
NNN
$7.96B
| $59.3M | 0.02% |
1,448,818
+44,416
| +3% | +$1.82M |
|
323
Axsome Therapeutics
AXSM
$6.15B
| $59M | 0.02% |
724,139
+492,133
| +212% | +$40.1M |
|
324
Blackrock
BLK
$171B
| $58.8M | 0.02% |
81,460
-76,145
| -48% | -$54.9M |
|
325
Landstar System
LSTR
$4.55B
| $58.4M | 0.02% |
433,511
+364,855
| +531% | +$49.1M |
|